Since RUNX1T1 silencing with short hairpin RNAs has shown in vitro therapeutic effects on AML cells with the RUNX1-RUNX1T1 fusion [5], RUNX1T1 overexpression has been suggested as a leukemogenesis factor. Here, RUNX1 is linked to acute myeloid leukemia.